Şunu aradınız:: clastogenic (İngilizce - Slovakça)

busulfan is mutagenic and clastogenic.
busulfán je mutagénny a klastogénny.

ruxolitinib was not mutagenic or clastogenic.
ruxolitinib nebol mutagénny alebo klastogénny.

sunitinib was not clastogenic in rat bone marrow in vivo.
u potkanov nebol sunitinib in vivo klastogénny v kostnej dreni.

teriflunomide was not mutagenic in vitro or clastogenic in vivo.
teriflunomid nebol mutagénny in vitro alebo klastogénny in vivo.

fingolimod was neither mutagenic nor clastogenic in animal studies.
fingolimod nebol mutagénny ani klastogénny v štúdiách na zvieratách.

efavirenz was not mutagenic or clastogenic in conventional genotoxicity assays.
efavirenz nevykazoval v klasických testoch genotoxicity ani mutagénne ani klastogénne vlastnosti.

lepirudin was not mutagenic or clastogenic in standard assays for such effects.
v štandarných skúškach nevykazoval lepirudín mutagénne ani klastogénne účinky.

this mutagenic effect could be attributed to a clastogenic effect of rotigotine.
mutagénny účinok je možné pripísať klastogénnemu účinku rotigotínu.

ambrisentan was clastogenic when tested at high concentrations in mammalian cells in vitro.
ambrisentan bol klastogénny, keď sa testoval vo vysokých koncentráciách v cicavčích bunkách in vitro.

pemetrexed has been shown to be clastogenic in the in vivo micronucleus test in the mouse.
v mikronukleárnom teste in vivo u myší bolo zistené, že pemetrexed je klastogénny.

olaparib showed no mutagenic potential, but was clastogenic in mammalian cells in vitro.
olaparib nepreukázal žiadny mutagénny potenciál, ale bol klastogénny v cicavčích bunkách in vitro.

daptomycin was not mutagenic or clastogenic in a battery of in vivo and in vitro genotoxicity tests.
v batérii testov genotoxicity vykonávaných in vivo aj in vitro nebol daptomycín mutagénny ani klastogénny.

dasatinib was clastogenic in vitro to dividing chinese hamster ovary (cho) cells.
dasatinib mal klastogénny účinok in vitro na deliace sa ovariálne bunky škrečka (cho).

eribulin was positive in the mouse lymphoma mutagenesis assay and was clastogenic in the in vivo rat micronucleus assay.
eribulín bol pozitívny v teste mutagenézy na myšacích lymfómoch a bol klastogénny v mikronukleovom teste in vivo u potkanov.

teysuno was clastogenic in vitro using chinese hamster lung cells and was weakly clastogenic in vivo in mouse bone marrow.
teysuno bol in vitro klastogénny, na pľúcnych bunkách čínskeho škrečka a in vivo bol slabo klastogénny na kostnej dreni myší.

apremilast was not clastogenic in an in vivo mouse micronucleus assay at doses up to 2000 mg/kg/day.
apremilast nebol pri dávkach do 2 000 mg/kg/deň klastogénny v in vivo mikronukleárnom teste u myší.

non-clinical data reveal no special safety risk for humans based on studies of safety pharmacology, mutagenicity and clastogenic potential.
predklinické údaje získané na základe obvyklých farmakologických štúdií bezpečnosti, mutagenity a klastogénneho potenciálu neodhalili žiadne osobitné riziko pre ľudí.

deferiprone did not show direct mutagenic properties; however, it did display clastogenic characteristics in in vitro assays and in vivo in animals.
deferiprón nepreukázal priame mutagénne vlastnosti, avšak mal klastogénne charakteristiky v in vitro skúškach a in vivo u zvierat.

ferric citrate was neither mutagenic in the bacterial reverse mutation assay (ames test) nor clastogenic in the chromosomal aberration test in chinese hamster fibroblasts.
citran železitý nebol mutagénny v analýze bakteriálnej reverznej mutácie (amesov test) ani klastogénny v teste chromozómovej aberácie vo fibroblastoch škrečka čínskeho.

adler, i.d., (1986) clastogenic potential in mouse spermatogonia of chemical mutagens related to their cell-cycle specifications.
adler, i.d.